AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Aker BioMarine

Regulatory Filings • Nov 14, 2023

3527_rns_2023-11-14_ac6db8dc-7983-439a-a655-70ea1d927adc.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

Aker BioMarine to present at Jefferies Healthcare Conference 2023

14 November 2023: Aker BioMarine’s CEO, Matts Johansen, will be speaking at Jefferies Healthcare Conference tomorrow 15 November 2023 at 11.00 CET.

Attached you will find the presentation.

For further information, please contact

Christopher Robin Vinter, VP IR & Corporate Finance

Mobile: +47 911 60 820

Email: [email protected]

About Aker BioMarine

Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting company developing krill-derived products for consumer health and wellness as well as animal nutrition. The company has a strong position in its industry and is the world's leading supplier of krill, the natural, powerful and health promoting source of nutrients from the pristine waters of Antarctica. Aker BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.